ASST vs. ARCT
ASST (Asset Entities Inc. Class B Common Stock) and ARCT (Arcturus Therapeutics Holdings Inc.) are both stocks. ASST operates in Internet Content & Information (Communication Services), while ARCT operates in Biotechnology (Healthcare). Over the past 3 years, ASST returned -56.18%/yr vs -37.62%/yr for ARCT. At a 0.13 correlation, their price movements are largely independent.
Performance
ASST vs. ARCT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ASST achieves a 2.64% return, which is significantly lower than ARCT's 13.70% return.
ASST
- 1D
- 3.91%
- 1M
- -9.77%
- YTD
- 2.64%
- 6M
- -12.25%
- 1Y
- -86.92%
- 3Y*
- -56.18%
- 5Y*
- —
- 10Y*
- —
ARCT
- 1D
- 0.00%
- 1M
- -6.69%
- YTD
- 13.70%
- 6M
- -6.57%
- 1Y
- -43.70%
- 3Y*
- -37.62%
- 5Y*
- -27.33%
- 10Y*
- —
ASST vs. ARCT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
ASST Asset Entities Inc. Class B Common Stock | 2.64% | 50.46% | -84.65% | -89.13% |
ARCT Arcturus Therapeutics Holdings Inc. | 13.70% | -63.88% | -46.18% | 37.63% |
Correlation
The correlation between ASST and ARCT is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Feb 3, 2023 | 0.13 |
The correlation between ASST and ARCT shifts across timeframes, from 0.11 (3 years) to 0.22 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
ASST:
$933.69M
ARCT:
$198.09M
ASST:
-$25.54
ARCT:
-$1.81
ASST:
71.38
ARCT:
4.10
ASST:
$5.73M
ARCT:
$46.80M
ASST:
-$7.43M
ARCT:
$40.72M
ASST:
-$304.63M
ARCT:
-$84.61M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ASST vs. ARCT — Risk / Return Rank
ASST
ARCT
ASST vs. ARCT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Asset Entities Inc. Class B Common Stock (ASST) and Arcturus Therapeutics Holdings Inc. (ARCT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ASST | ARCT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.05 | ||
| Sortino ratioReturn per unit of downside risk | -0.69 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 0.98 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | -0.92 | -0.60 | -0.31 |
| Martin ratioReturn relative to average drawdown | -1.12 | -0.83 | -0.29 |
Loading charts...
Drawdowns
ASST vs. ARCT - Drawdown Comparison
The maximum ASST drawdown since its inception was -98.78%, roughly equal to the maximum ARCT drawdown of -95.23%. Use the drawdown chart below to compare losses from any high point for ASST and ARCT.
Loading charts...
Drawdown Indicators
| ASST | ARCT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.78% | -95.23% | -3.55% |
Max Drawdown (1Y)Largest decline over 1 year | -95.98% | -74.53% | -21.45% |
Max Drawdown (3Y)Largest decline over 3 years | -97.25% | -86.71% | -10.54% |
Max Drawdown (5Y)Largest decline over 5 years | — | -89.87% | — |
Current DrawdownCurrent decline from peak | -97.42% | -94.36% | -3.06% |
Average DrawdownAverage peak-to-trough decline | -90.39% | -73.03% | -17.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 78.47% | 54.00% | +24.47% |
Volatility
ASST vs. ARCT - Volatility Comparison
Asset Entities Inc. Class B Common Stock (ASST) has a higher volatility of 23.80% compared to Arcturus Therapeutics Holdings Inc. (ARCT) at 18.29%. This indicates that ASST's price experiences larger fluctuations and is considered to be riskier than ARCT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ASST | ARCT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.80% | 18.29% | +5.51% |
Volatility (6M)Calculated over the trailing 6-month period | 81.69% | 40.18% | +41.51% |
Volatility (1Y)Calculated over the trailing 1-year period | 162.68% | 92.49% | +70.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 322.54% | 91.80% | +230.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 322.54% | 102.11% | +220.43% |
Dividends
ASST vs. ARCT - Dividend Comparison
Neither ASST nor ARCT has paid dividends to shareholders.
Financials
ASST vs. ARCT - Financials Comparison
This section allows you to compare key financial metrics between Asset Entities Inc. Class B Common Stock and Arcturus Therapeutics Holdings Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ASST and ARCT have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ASST has higher volatility (23.80%) compared to ARCT (18.29%). In terms of maximum drawdown, ASST dropped -98.78% vs ARCT's -95.23%.
ARCT currently has the higher Sharpe Ratio (-0.49 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ASST and ARCT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer